Clalit HMO: 94% drop in symptomatic infections in vaccinated people

A new study by Israel’s largest healthcare provider, Clalit, shows a 94% drop in symptomatic infections in people vaccinated for coronavirus, and a 92% drop in serious illness among those who do fall ill.

The study reviewed 600,000 people who’ve received the second dose of the Pfizer vaccine and compared them to 600,000 people not yet vaccinated. The study compared vaccinated individuals to unvaccinated ones with similar medical characteristics, allowing a very detailed examination of the vaccine’s effect, the HMO says.

It shows the vaccine is as effective in people over 70 as it is in younger individuals.

The study follows one by the Maccabi HMO published last week that showed that of half a million people vaccinated with both doses of the Pfizer vaccine, only 544 people — or 0.1% — were subsequently diagnosed with coronavirus, only four suffered severe illness, and none died.

A woman receives a COVID-19 vaccine at a vaccination center in Safed on February 14, 2021 (David Cohen/Flash90)

Most Popular
If you’d like to comment, join
The Times of Israel Community.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.